aid: elephas-biosciences name: Elephas Biosciences description: 'Elephas Biosciences Corporation is a Madison, Wisconsin precision-oncology company that builds elive, a first-in-class functional immune-profiling platform that measures how a patient''s own live tumor tissue responds to immunotherapy. The platform combines elive Edge (an automated instrument that cuts core-needle biopsies into uniform 300-micron viable fragments), elive Gel (a proprietary hydrogel that preserves the native tumor microenvironment) and the elive Method (a sequential treatment and cytokine-analysis strategy) to return a functional response readout within roughly 72 hours of biopsy. Clinicians receive elive test reports through a secure, cloud-based web application; researchers and drug developers receive custom reports plus raw data for in-house analysis. The company raised a $40M Series B-2 in November 2025 to commercialize elive as a laboratory developed test. Its digital surface is the Elephas Portal (portal.elephas.com), an Angular single-page application backed by an ASP.NET Core API at portal.elephasapis.com that is authenticated with Azure AD B2C on the company-controlled na.login.elephas.com identity host. No public developer program, API reference or machine-readable contract is published.' image: https://elephas.com/hubfs/raw_assets/public/ele_2026/images/ele-logo-tagline.svg url: https://raw.githubusercontent.com/api-evangelist/elephas-biosciences/refs/heads/main/apis.yml x-type: company x-source: harvest:secondary-market specificationVersion: '0.23' created: '2026-08-12' modified: '2026-08-12' tags: - Company - Healthcare - Life Sciences - Biotechnology - Precision Oncology - Diagnostics - Immunotherapy - Clinical Research - Laboratory - Medical Devices apis: - aid: elephas-biosciences-portal-api name: Elephas Portal API description: 'The private backend API behind the Elephas Portal, the secure cloud-based web application through which clinicians, laboratories and research partners receive elive test reports and manage specimen registration. Probed live at https://portal.elephasapis.com: an ASP.NET Core (Kestrel) service that answers every path — including /swagger and /swagger/v1/swagger.json — with HTTP 401 and a WWW-Authenticate: Bearer challenge. Bearer tokens are issued by Azure AD B2C on the company-controlled host na.login.elephas.com. No public OpenAPI, reference or developer program is published; the observed surface (registration, security, histology, cytokines, cut-culture resources) is inferred only from the portal single-page application bundle and is recorded here as evidence of an API that exists but is not publicly documented.' humanURL: https://portal.elephas.com/ baseURL: https://portal.elephasapis.com tags: - Portal - Oncology - Diagnostics - Reports properties: - type: Authentication url: authentication/elephas-biosciences-authentication.yml - type: OAuthScopes url: scopes/elephas-biosciences-scopes.yml - type: ErrorCatalog url: errors/elephas-biosciences-problem-types.yml - type: Conventions url: conventions/elephas-biosciences-conventions.yml maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: Website url: https://elephas.com/ - type: Login url: https://portal.elephas.com/ - type: Support url: https://elephas.com/get-in-touch - type: Blog url: https://elephas.com/news - type: BlogRSS url: https://elephas.com/news/rss.xml - type: TermsOfService url: https://elephas.com/terms-of-service - type: PrivacyPolicy url: https://elephas.com/privacy-policy - type: FAQ url: https://elephas.com/faqs - type: Documents url: https://elephas.com/resources/documents - type: Publications url: https://elephas.com/resources/publications - type: Careers url: https://elephas.com/careers - type: LinkedIn url: https://www.linkedin.com/company/elephasbiosciences - type: Crunchbase url: https://www.crunchbase.com/organization/elephas-biosciences - type: WellKnown url: well-known/elephas-biosciences-well-known.yml - type: Authentication url: authentication/elephas-biosciences-authentication.yml - type: OAuthScopes url: scopes/elephas-biosciences-scopes.yml - type: DomainSecurity url: security/elephas-biosciences-domain-security.yml - type: ErrorCatalog url: errors/elephas-biosciences-problem-types.yml - type: Conventions url: conventions/elephas-biosciences-conventions.yml - type: Conformance url: conformance/elephas-biosciences-conformance.yml - type: Plans url: plans/elephas-biosciences-plans-pricing.yml - type: RateLimits url: rate-limits/elephas-biosciences-rate-limits.yml - type: LLMsTxt url: llms/elephas-biosciences-llms.txt x-enrichment: date: '2026-08-12' status: minimal artifacts_added: 12 pass: local-v1 x-coverage: state: gated reason: customer-only-docs detail: 'Elephas runs a real ASP.NET Core API at portal.elephasapis.com behind the Elephas Portal, but every path on it — including /swagger and /swagger/v1/swagger.json — answers HTTP 401 with a WWW-Authenticate: Bearer challenge, and tokens are only issuable to an existing Elephas tenant through Azure AD B2C, so the Swagger contract the service already generates is readable only by active customers.' evidence: - url: https://portal.elephasapis.com/swagger/v1/swagger.json status: 401 - url: https://portal.elephasapis.com/swagger status: 401 - url: https://elephas.com/developers status: 404 - url: https://elephas.com/llms.txt status: 404 - url: https://na.login.elephas.com/bf865bf1-740f-49ec-922c-9b2c233faa13/B2C_1A_SMART_HRD_SUSI/v2.0/.well-known/openid-configuration status: 200 checked: '2026-08-12'